CompoundIQ

Disclaimer

CompoundIQ publishes research summaries for informational and educational purposes only. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. Always consult a licensed healthcare provider. Many compounds listed are research chemicals not approved for human use.

SteroidAdvancedHigh Risk

Trestolone

Also known as: MENT, Trestolone Acetate, 7-alpha-methyl-19-nortestosterone

Trestolone (MENT) is a synthetic 19-nortestosterone derivative originally investigated as a potential male contraceptive and androgen replacement therapy. It is roughly 10 times more potent than testosterone and does not undergo 5-alpha reduction, making it highly anabolic. It has gained significant popularity in underground steroid communities.

Evidence35/100 — Emerging

Risk Level

High Risk

Difficulty

Advanced
CAS Number3764-87-2
Molecular FormulaC19H28O2
ClassSteroid
CategoryUnderground Steroids

Mechanism of Action

A 7-alpha-methylated 19-nortestosterone that binds androgen receptors with very high affinity. Does not convert to DHT via 5-alpha reductase. Aromatizes to 7-alpha-methylestradiol, a potent estrogen. Has strong progestogenic activity. Its resistance to 5-alpha reduction means it maintains full potency in all tissues including muscle, prostate, and scalp.

Dosing Research

Acetate ester typically dosed at 5-25 mg per day via daily injection or 10-50 mg every other day. Due to extreme potency, much lower doses are used compared to testosterone. Decanoate ester allows weekly injections at 50-200 mg per week. Cycles typically 8-16 weeks. Often run as a standalone or with a low-dose testosterone base.

Side Effects & Risks

Heavy aromatization to a potent estrogen requires aggressive estrogen management. Progestogenic side effects possible. Significant HPTA suppression — was designed as a male contraceptive. Blood pressure elevation and cardiovascular strain. Limited long-term safety data in humans. Can cause rapid onset gynecomastia if estrogen is uncontrolled.

Research Studies

Disclaimer

CompoundIQ publishes research summaries for informational and educational purposes only. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. Always consult a licensed healthcare provider. Many compounds listed are research chemicals not approved for human use.

Send Feedback

Help us improve CompoundIQ